Skin Diseases Associated with Biologic Therapies

Sharon Rose; Shivani B. Kaushik; Mark Lebwohl

doi:10.1007/978-3-319-68790-2_8

Skin Diseases Associated with Biologic Therapies

Sharon Rose
, Shivani B. Kaushik
, Mark Lebwohl

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Biologics have become the mainstay of many dermatological and systemic diseases in our current practice. While safety and efficacy of these drugs has been proven extensively in clinical trials, these drugs possess the potential for cutaneous as well as systemic toxicity owing to their immunosuppressive effects. This book chapter focuses on the adverse cutaneous reactions observed with biologics, specifically tumor necrosis factor-alpha inhibitors. These side effects can include but are not limited to injection site reactions, hypersensitivity reactions, psoriasiform eruptions, eczema, vasculitis, and lupus-like reactions.

Original language	English
Title of host publication	Coresource 4
Publisher	Springer International Publishing
Pages	155-165
Number of pages	11
ISBN (Electronic)	9783319687902
ISBN (Print)	9783319687889
DOIs	https://doi.org/10.1007/978-3-319-68790-2_8
State	Published - 2018

Keywords

Biologics
Psoriasis
Skin reaction
TNF-alpha

Access to Document

10.1007/978-3-319-68790-2_8

Cite this

@inbook{a9e6d1c121804b80ad3d52d49374e2fe,

title = "Skin Diseases Associated with Biologic Therapies",

abstract = "Biologics have become the mainstay of many dermatological and systemic diseases in our current practice. While safety and efficacy of these drugs has been proven extensively in clinical trials, these drugs possess the potential for cutaneous as well as systemic toxicity owing to their immunosuppressive effects. This book chapter focuses on the adverse cutaneous reactions observed with biologics, specifically tumor necrosis factor-alpha inhibitors. These side effects can include but are not limited to injection site reactions, hypersensitivity reactions, psoriasiform eruptions, eczema, vasculitis, and lupus-like reactions.",

keywords = "Biologics, Psoriasis, Skin reaction, TNF-alpha",

author = "Sharon Rose and Kaushik, \{Shivani B.\} and Mark Lebwohl",

note = "Publisher Copyright: Springer International Publishing AG, part of Springer Nature 2018.",

year = "2018",

doi = "10.1007/978-3-319-68790-2\_8",

language = "English",

isbn = "9783319687889",

pages = "155--165",

booktitle = "Coresource 4",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Skin Diseases Associated with Biologic Therapies

AU - Rose, Sharon

AU - Kaushik, Shivani B.

AU - Lebwohl, Mark

N1 - Publisher Copyright: Springer International Publishing AG, part of Springer Nature 2018.

PY - 2018

Y1 - 2018

N2 - Biologics have become the mainstay of many dermatological and systemic diseases in our current practice. While safety and efficacy of these drugs has been proven extensively in clinical trials, these drugs possess the potential for cutaneous as well as systemic toxicity owing to their immunosuppressive effects. This book chapter focuses on the adverse cutaneous reactions observed with biologics, specifically tumor necrosis factor-alpha inhibitors. These side effects can include but are not limited to injection site reactions, hypersensitivity reactions, psoriasiform eruptions, eczema, vasculitis, and lupus-like reactions.

AB - Biologics have become the mainstay of many dermatological and systemic diseases in our current practice. While safety and efficacy of these drugs has been proven extensively in clinical trials, these drugs possess the potential for cutaneous as well as systemic toxicity owing to their immunosuppressive effects. This book chapter focuses on the adverse cutaneous reactions observed with biologics, specifically tumor necrosis factor-alpha inhibitors. These side effects can include but are not limited to injection site reactions, hypersensitivity reactions, psoriasiform eruptions, eczema, vasculitis, and lupus-like reactions.

KW - Biologics

KW - Psoriasis

KW - Skin reaction

KW - TNF-alpha

UR - https://www.scopus.com/pages/publications/105042959181

U2 - 10.1007/978-3-319-68790-2_8

DO - 10.1007/978-3-319-68790-2_8

M3 - Chapter

AN - SCOPUS:105042959181

SN - 9783319687889

SP - 155

EP - 165

BT - Coresource 4

PB - Springer International Publishing

ER -

Skin Diseases Associated with Biologic Therapies

Abstract

Keywords

Access to Document

Fingerprint

Cite this